Giorgio Tarchini. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Aminoglycosides/pharmacokineticsAminoglycosides/therapeutic useAnti-Bacterial Agents/pharmacokineticsAnti-Bacterial Agents/therapeutic useCross Infection/drug therapyCross Infection/microbiologyGram-Positive Bacterial Infections/drug therapyGram-Positive Bacterial Infections/microbiologyHumansLipoglycopeptidesPneumonia, Bacterial/drug therapyPneumonia, Bacterial/microbiologyTreatment OutcomeVancomycin/pharmacokineticsVancomycin/therapeutic use
Substances: See more » AminoglycosidesAnti-Bacterial AgentsLipoglycopeptidesVancomycintelavancin
Year: 2011 PMID: 21596683 DOI: 10.1093/cid/cir189
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079